Internal Medicine

Researchers at Wake Forest Baptist Medical Center have released a study showing the potential of a dangerous interaction between a common supplement and prescription medication.

For patients enduring constant pain in their ankles caused by arthritis, there could be relief on the horizon as medical science works to develop better ankle replacement procedures.

Early research at Columbia University could provide a breakthrough in the treatment of diabetes.

The Food and Drug Administration (FDA) has announced the approval of a new medication aimed at helping the nearly 26 million people in the country with diabetes.

Avik Roy, Senior Fellow at the Manhattan Institute for Policy Research, Opinion Editor of Forbes, and Editor of The Apothecary blog about healthcare and entitlement reform, breaks down the intricacies of the Affordable Care Act for internists.

Among patients aged 65 years or older who are hospitalized with community-acquired pneumonia, azithromycin lowers the risk of 90-day mortality in exchange for slightly increased odds of myocardial infarction compared to other antibiotic regimens.

A taskforce from the European Academy of Allergy and Clinical Immunology has reviewed all the published research and formulated a new set of comprehensive guidelines for diagnosing and treating anaphylaxis.

The newest tool in the fight against drug-resistant germs may come from underneath the feet of people in Nova Scotia.

Researchers in Australia believe they have found what had been a missing link between low levels of vitamin D and hypertension.

A rapid test under development in Europe could go a long way in helping doctors in hospitals identify strains of pathogens that would be resistant to commonly used broad-spectrum antibiotics.

If the results of a recent study are proven to last, then the previously held belief concerning the relationship between tuberculosis and the use of corticosteroids could be considered incomplete.

Minutes and seconds can make a difference in the amount of brain damage suffered by a stroke patient, but now scientists have shown that medication can significantly help limit the damage.

Under current quality measures, colorectal screenings are being overused in sick elderly patients and underused in healthy ones.

Patients with psoriasis, psoriatic arthritis, or both conditions felt their quality of life decreased if they experienced condition symptoms in more parts of their body.

Cardiovascular risk related to severity of inflammation, but not associated with disease duration

Men who have sex with men and women (MSMW) have unique vulnerability to HIV and sexually transmitted infections (STIs) and other sexual health problems, according to a review published online June 22 in American Journal of Preventive Medicine.

European regulators recently approved alemtuzumab to treat active relapsing-remitting multiple sclerosis, but the US Food and Drug Administration denied the drug for that indication last year.

Although tofacitinib is typically used to treat rheumatoid arthritis, researchers at Yale University discovered the drug effectively reversed alopecia universalis in a patient with plaque psoriasis.

Patients with osteoporosis got some good news at a recent conference when the results of a study showed that taking the drug denosumab can help increase bone density and keep their rate of fractures at a low level.

A new pill could be the next tool in a patient's fight to lose weight, according to a recent study.

New research financed by Medtronic Inc. suggests that implantable cardiac resynchronization therapy devices governed by its new algorithms may reduce atrial fibrillation-related complications in patients who have experienced heart failure.

In Europe and the United States, more than 3 million people suffer from either Crohn's disease or ulcerative colitis, and while they are becoming more common diagnoses, the root causes and triggers are not completely clear to researchers.

Obese and overweight patients who were treated with the drug liraglutide experienced significant weight loss and were less likely to develop type 2 diabetes than patients who received placebo.

A drug which has already been approved for patients with diabetes could have more benefits for people at risk of having heart disease, according a recent study.

A recent study found that the hepatitis C virus decays during treatment with telaprevir faster in the bloodstream than it does in the liver, a discovery that could help pinpoint how long a patient needs to take medicine to rid the virus from the body.

Although many primary care physicians remain uncertain of how to best help patients in pain manage their opioid prescriptions, new research shows a standardized protocol based on electronic medical records can get patients the assistance they need while providing peace of mind to prescribers.

A recent study of patients who underwent bariatric surgery showed that even while their weight settled following their procedure their bone loss continued even two years after the operation.

An experimental, first-in-class drug that affects the gut microbiota has been shown to improve glucose tolerance and insulin sensitivity in adults with prediabetes.

A new factor in sleep and sleep apnea among obese and overweight men was introduced by researchers at a recent conference, pointing to the man's testosterone levels as helping determine sleep quality.

This marks the first testosterone nasal gel for replacement therapy in adult males approved by the FDA for conditions associated with a deficiency or absence of endogenous testosterone.